Ronald Ackerman, MD
Gynecology · West Palm Beach, FLNPI 1942356621
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,235 of the $6,787 with a category attached, or 77.1%. Eli Lilly accounts for 65.0% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $6,357, more than ten times the $60 reported in 2019.
Across 32 payments — averaging $212.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$4K
- Genbiopro, Inc.$2K
- Astellas Pharma US Inc$127
- Hologic Sales And Service, LLC$74
- Aspira Women's Health Inc$45
- Kowa Pharmaceuticals America, Inc.$38
- plus $232 from 9 others
Across 610 payments — averaging $9715.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$1.4M
- Abbott$1M
- Cepheid$671K
- AbbVie$420K
- Gen-probe, Inc.$310K
- Novavax Inc$298K
- plus $1.8M from 20 others
What the payments were for
- Consulting fees$5,23577%
- Speaking & faculty fees$160%
- Travel & lodging$86013%
- Food & beverage$66310%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 5 | $4,412 |
| Genbiopro, Inc. | 1 | $1,860 |
| Astellas Pharma US Inc | 6 | $127 |
| Hologic Sales And Service, LLC | 4 | $74 |
| Aspira Women's Health Inc | 3 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| AbbVie | 2 | $37 |
| Coopersurgical, Inc. | 1 | $37 |
| Millicent US Inc | 2 | $36 |
| Dysis Medical, Inc. | 1 | $34 |
| Bayer | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Avion Pharmaceuticals | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$6,787 in reported general payments places this provider in the 85th percentile of 290 gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 15 | $200 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $179 |
Paid to pharmacies, not to this prescriber.
Other gynecology in West Palm Beach
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Meenakshi JainSt Petersburg$35K
- Michael SpragueWeston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.